{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:49:36Z","timestamp":1760888976738,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000575","name":"The British Toxicology Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000575","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Centre for Toxicology, University of Surrey"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.tox.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T02:04:03Z","timestamp":1420682643000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity"],"prefix":"10.1016","volume":"329","author":[{"given":"Rowena H.","family":"Gee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny N.","family":"Spinks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Malia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-8308","authenticated-orcid":false,"given":"Nick J.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2015.01.005_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.taap.2012.05.016","article-title":"Non-coplanar polychlorinated biphenyls (PCBs) are direct agonists for the human pregnane-X receptor and constitutive androstane receptor, and activate target gene expression in a tissue-specific manner","volume":"263","author":"Al-Salman","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1074248406288758","article-title":"Statin-induced myopathy: the two faces of Janus","volume":"11","author":"Arora","year":"2006","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2015.01.005_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bjorkhem-Bergman","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(01)00613-X","article-title":"3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation","volume":"161","author":"Blanco-Colio","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tox.2015.01.005_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.LAB.0000065015.02412.48","article-title":"Detection of the human organic anion transporters SLUM (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma","volume":"83","author":"Cui","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tox.2015.01.005_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.008391","article-title":"Conserved valproic-acid-induced lipid droplet formation in dictyostelium and human hepatocytes identifies structurally active compounds","volume":"5","author":"Elphick","year":"2012","journal-title":"Dis. Models Mechan."},{"key":"10.1016\/j.tox.2015.01.005_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.tox.2015.01.005_bib0040","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tox.2015.01.005_bib0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.RES.83.5.490","article-title":"3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture","volume":"83","author":"Guijarro","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.tox.2015.01.005_bib0050","doi-asserted-by":"crossref","first-page":"17508","DOI":"10.1074\/jbc.270.29.17508","article-title":"Differential effects of monoterpenes and lovastatin on RAS processing","volume":"270","author":"Hohl","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/00498254.2011.569773","article-title":"The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes","volume":"41","author":"Howe","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2015.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tox.2015.01.005_bib0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1254\/jphs.08238FP","article-title":"Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats","volume":"109","author":"Itagaki","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.tox.2015.01.005_bib0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.taap.2004.04.010","article-title":"Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone","volume":"200","author":"Johnson","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1211\/146080899128734820","article-title":"Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors by their relative lipophilicity","volume":"5","author":"Joshi","year":"1999","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.tox.2015.01.005_bib0080","first-page":"2042","article-title":"Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD1","volume":"58","author":"Knudsen","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2015.01.005_bib0085","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1038\/ncomms2799","article-title":"Optimization of stress response through the nuclear receptor-mediated cortisol signalling network","volume":"4","author":"Kolodkin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tox.2015.01.005_bib0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/msb.2010.102","article-title":"Design principles of nuclear receptor signaling: how complex networking improves signal transduction","volume":"6","author":"Kolodkin","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.tox.2015.01.005_bib0095","doi-asserted-by":"crossref","first-page":"26802","DOI":"10.1074\/jbc.270.45.26802","article-title":"Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic RAS signaling by inducing cytoplasmic accumulation of inactive RAS\u2013RAF complexes","volume":"270","author":"Lerner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00204-011-0733-y","article-title":"Comparative analysis of phases I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism","volume":"86","author":"Lin","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2015.01.005_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tox.2015.01.005_bib0115","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1211\/jpp.57.11.0014","article-title":"Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein","volume":"57","author":"Matzno","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M","article-title":"Cultivation in vitro of cells derived from a human rhabdomyosarcoma","volume":"24","author":"McAllister","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.tox.2015.01.005_bib0125","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.0907117106","article-title":"Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans","volume":"106","author":"Morck","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2015.01.005_bib0130","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bcp.2009.12.007","article-title":"Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells: and consequences for statin-induced myopathy","volume":"79","author":"Mullen","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0135","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.bbamcr.2011.07.019","article-title":"Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt","volume":"1813","author":"Mullen","year":"2011","journal-title":"Biochim. Biophys. Acta: Mol. Cell Res."},{"key":"10.1016\/j.tox.2015.01.005_bib0140","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2015.01.005_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2007.05.005","article-title":"Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs","volume":"223","author":"Nishimoto","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0150","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bcp.2003.08.011","article-title":"Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes","volume":"66","author":"Nishimoto","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pharmtox-010510-100556","article-title":"The expression and function of organic anion transporting polypeptides in normal tissues and in cancer","volume":"52","author":"Obaidat","year":"2012","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2015.01.005_bib0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2008.10.019","article-title":"The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1","volume":"235","author":"Plant","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.01.005_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1359-6446(03)03019-8","article-title":"Strategies for using in vitro screens in drug metabolism","volume":"9","author":"Plant","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tox.2015.01.005_bib0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bbagen.2006.09.024","article-title":"The human cytochrome P450 3A sub-family: transcriptional regulation, inter-individual variation and interaction networks","volume":"1770","author":"Plant","year":"2007","journal-title":"Biochim. Biophys. Acta \u2013 Gen. Subjects"},{"key":"10.1016\/j.tox.2015.01.005_bib0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0968-0896(97)10040-2","article-title":"Selective inhibition of type-I geranylgeranyltransferase in vitro and in whole cells by CAAL peptidomimetics","volume":"6","author":"Qian","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0180","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1073\/pnas.1218778110","article-title":"The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway","volume":"110","author":"Rauthan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2015.01.005_bib0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/aps.2009.85","article-title":"The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells","volume":"30","author":"Rodrigues","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tox.2015.01.005_bib0190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ejca.2010.12.010","article-title":"Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways","volume":"47","author":"Rossi","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2015.01.005_bib0195","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1096\/fj.07-8713com","article-title":"Rab-small GTPases are involved in fluvastatin and pravastatin-induced vacuolation in rat skeletal myofibers","volume":"21","author":"Sakamoto","year":"2007","journal-title":"Faseb J."},{"key":"10.1016\/j.tox.2015.01.005_bib0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/jpet.111.179762","article-title":"Inhibition of Rab1 GTPase and endoplasmic reticulum-to-golgi trafficking underlies statin's toxicity in rat skeletal myofibers","volume":"338","author":"Sakamoto","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2015.01.005_bib0205","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1074\/jbc.M009165200","article-title":"3-hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells \u2013 involvement of geranylgeranylation of small G protein Rap1","volume":"276","author":"Satoh","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jps.2600800905","article-title":"Relative lipophilicities, solubilities, and structure pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme-A (Hmg-Coa) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin","volume":"80","author":"Serajuddin","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2015.01.005_bib0215","doi-asserted-by":"crossref","first-page":"38353","DOI":"10.1074\/jbc.M404838200","article-title":"Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways","volume":"279","author":"Siddals","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.01.005_bib0220","doi-asserted-by":"crossref","first-page":"e39581","DOI":"10.1371\/journal.pone.0039581","article-title":"Statin treatment increases lifespan and improves cardiac health in drosophila by decreasing specific protein prenylation","volume":"7","author":"Spindler","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.tox.2015.01.005_bib0225","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tox.2015.01.005_bib0230","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.110.175521","article-title":"Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate","volume":"337","author":"Wasko","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2015.01.005_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623307311412","article-title":"Rosuvastatin: characterization of induced myopathy in the Rat","volume":"36","author":"Westwood","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2015.01.005_bib0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Ann. Rev. Biochem."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:29:23Z","timestamp":1759534163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X15000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":48,"alternative-id":["S0300483X15000062"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2015.01.005","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}